Sunday, June 6, 2021

FDA approves obesity drug that helped people cut their weight by 15%

Regulators on Friday said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S.. The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk's diabetes drug semaglutide.